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Abstract: 
Manganese (Mn) exposure interferes with GABA uptake; however, the effects of Mn on GABA 
transport proteins (GATs) have not been identified. We sought to characterize how Mn impairs 
GAT function in primary rat astrocytes. Astrocytes exposed to Mn (500 μM) had significantly 
reduced 3H-GABA uptake despite no change in membrane or cytosolic GAT3 protein levels. Co-
treatment with 100 μM oleic or palmitic acids (both known to be elevated in Mn neurotoxicity), 
exacerbated the Mn-induced decline in 3H-GABA uptake. Mn accumulation in the membrane 
fraction of astrocytes was enhanced with fatty acid administration, and was negatively correlated 
with 3H-GABA uptake. Furthermore, control cells exposed to Mn only during the experimental 
uptake had significantly reduced 3H-GABA uptake, and the addition of GABA (50 μM) blunted 
cytosolic Mn accumulation. These data indicate that reduced GAT function in astrocytes is 
influenced by Mn and fatty acids accumulating at or interacting with the plasma membrane. 
Abbreviations: Mn, manganese; GABA, γ-aminobutyric acid; GAT, GABA 
transporter; PKC, protein kinase C; pPKC,phosphorylated PKC; PMA, phorbol 12-myristate 13-
acetate; Slc, solute carrier family; D-MEM,Dulbecco's minimal essential 
medium; ISO, isorhamnetin; PBS, phosphate buffered saline; RIPA,radioimmunoprecipitation 
assay; BIS II, bisindolylmaleimide II; DFO, desferrioxamine; DAT, dopamine transporter 
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Article: 
1. Introduction 
Manganese (Mn) neurotoxicity is associated with distinct neurochemical changes that contribute 
to extrapyramidal symptoms similar to Parkinson's disease. While most of the phenotypic 
changes resulting from prolonged Mn exposure are associated with changes in the dopamine 
system, evidence shows that Mn induced changes in the GABA neurotransmission exist prior to 
dopaminergic dysfunction (Gwiazda et al., 2002). GABA is the main inhibitory neurotransmitter 
in the brain that is responsible for modulating excitatory signals within the basal ganglia to help 
coordinate smooth motor function. Motor control issues observed with Mn exposure (e.g. 
bradykinesia) and other artifacts of Mn accumulation, such as glutamate excitotoxicity, may 
result from disrupted GABA signaling (Erikson and Aschner, 2003). Specific mechanisms as to 
how Mn alters GABA are unclear, but Mn appears to target GABA uptake leading to a greater 
than 3-fold increase in extracellular GABA (Fordahl et al., 2010). GABA clearance is mediated 
by pre- and extra-synaptic GABA transport proteins GAT1 and GAT3, respectively (Kersanté et 
al., 2012). Astrocytes primarily express the GAT3 isoform and are integral to clear GABA 
overflow from the synapse. The relatively high Km for GAT3 compared to neuronal GAT1 
(33 μM versus 7 μM, respectively) suggests that GAT3 plays a critical role in clearing GABA 
spillover from the synaptic cleft during Mn neurotoxicity. Under these conditions, GAT3 reduces 
the duration and intensity of inhibitory neurotransmission. Astrocytes also sequester Mn and 
other metals that pose a threat to more vulnerable neurons (Aschner et al., 1992); however, as 
Mn concentrations increase, the protective function of astrocytes and their role in GABA 
clearance may be jeopardized. 
Several studies have shown that Mn exposure disrupts GABA levels in tissue and extracellular 
space of the striatum (Bonilla, 1978, Gianutsos and Murray, 1982, Gwiazda et al., 2002, Takeda 
et al., 2002, Takeda et al., 2003, Anderson et al., 2008 and Fordahl et al., 2010). The direct effect 
of Mn on GABA transporters, however, has only been measured in striatal synaptosomes 
using 3H-GABA (Anderson et al., 2007a) and with in vivo microdialysis in Mn exposed rats after 
delivery of the GAT inhibitor nipecotic acid (Fordahl et al., 2010). These studies reveal a marked 
decline in GABA uptake, increased extracellular GABA, and impaired GAT protein function. 
Coupled with evidence that Mn exposure does not alter GAT protein or mRNA levels in Mn 
exposed rodents (Anderson et al., 2008), these findings suggest a functional decline in GABA 
transport proteins due to Mn. 
We hypothesize the decline in GABA transport is due to Mn altering cellular regulation of the 
GATs presumably through protein kinase C (PKC) signaling. PKC activation has been reported 
in dopaminergic N27 cells exposed to Mn (Latchoumycandane et al., 2005). Additionally, 
internalization of GATs from the plasma membrane to cytosolic vesicles is dependent on PKC 
phosphorylation of GATs (Gadea and Lopez-Colome, 2001 and Quick et al., 2004), but can be 
blocked by PKC inhibitors (Sato et al., 1995). Moreover, other solute carrier family (Slc) 
transporters, like the glutamine transporter SNAT3, are impaired by Mn induced activation of 
PKC (Sidoryk-Wegrzynowicz et al., 2011). Furthermore, recent data from our lab showed 
profound increases in oleic acid (12-fold), palmitic acid (15-fold) and cholesterol (4-fold) levels 
in brains of Mn exposed rats (Fordahl et al., 2012) and both oleic and palmitic acids are known 
modulators of PKC activity (Troeger et al., 1984, Khan et al., 1992 and Ragheb et al., 2009). 
Thus, the goals of our study are to: (1) specifically examine GABA uptake and GAT3 protein 
levels in primary astrocytes after Mn exposure, (2) investigate the role of PKC signaling in 
GAT3 regulation with the use of a PKC inhibitor quercetin, and (3) characterize the effect of 
oleic acid and palmitate on GAT3 protein levels and function. We hypothesized that Mn directly 
regulates GAT3 proteins through PKC signaling leading to transporter internalization, similar to 
other transport proteins in the solute carrier family. Additionally, we hypothesized that oleic acid 
and palmitate would exacerbate Mn induced GAT3 dysfunction. Lastly, we wanted to quantify 
Mn accumulation in cytosolic and membrane fractions of astrocytes to identify if Mn distribution 
within these cellular fractions is associated with GAT3 localization, PKC signaling, and/or 
GABA uptake. 
2. Methods 
2.1. Cell isolation and culture 
Cortical astrocytes were isolated from Sprague Dawley rat pups PND 1–3 (Harlan Laboratories) 
following the methods described by Allen et al. (2001) with slight modifications. All procedures 
were approved by the University of North Carolina Animal Care and Use Committee. Briefly, 
the pups were retrieved, cleaned using the antiseptic microbiocide Betadine, and swiftly 
decapitated. Using dissecting scissors and forceps the skull cap was detached and the brain was 
removed after carefully dissecting away any intact meninges to reduce fibroblast contamination. 
Once removed, well-defined cortices were carefully dissected apart from the rest of the brain and 
placed into serum free Dulbecco's minimal essential medium (D-MEM) (Sigma–Aldrich). The 
isolated tissue was minced by titration using a Pasteur pipette treated with Sigmacote®(Sigma–
Aldrich) to prevent cell lysing. Astrocytes were dissociated using a 1:5 dilution of Trypsin 0.05% 
in serum free D-MEM. Dissociated cells were removed and placed in D-MEM containing 10% 
heat inactivated horse serum (Sigma–Aldrich) to neutralize the Trypsin. Cells were plated in 
100 mm dishes at a density of 7.5 × 105 or 6-well plates at a density of 1.0 × 105 and 
maintained in a humidified atmosphere of 95% air/5% CO2 at 37 °C. Media were changed 
twice a week until cultures were 90% confluent. Culture purity was verified using 
immunocytochemistry where >95% stained positive for the astroglial marker GFAP (Invitrogen). 
Experimental treatments were as follows: 500 μM Mn in the form of MnCl2 was used for all 
Mn exposures unless otherwise indicated. This concentration of Mn is above physiologic levels, 
but has been demonstrated to be neurotoxic in astrocytes (Milatovic et al., 2007 and Milatovic et 
al., 2009) and falls in the symptomatic range of Mn neurotoxicity, 300 μM–1000 μM, as 
measured in the brains of non-human primates (Suzuki et al., 1975). Clinical data of Mn exposed 
humans show a greater than 3-fold accumulation in brain Mn compared to controls (Tracqui et 
al., 1995). 10 μM isorhamnetin (ISO) (Sigma–Aldrich), the methylated metabolite of quercetin 
and protein kinase C (PKC) inhibitor, was used as a pre- and co-treatment with Mn for uptake, 
western blot, and metal analyses. Isorhamnetin concentrations in rat plasma and brain have been 
reported at 15 μM and 200 nM, respectively (de Boer et al., 2005). Total GABA concentrations 
used in experiments were 50 μM representing physiologically relevant synaptic concentrations 
of GABA during inhibitory neurotransmission (Grabauskas, 2005). Logarithmic concentrations 
(10, 100, and 1000 μM) of albumin bound Oleic acid and palmitic acid (Sigma–Aldrich) were 
used for individual and co-treatment with Mn for all fatty acid experiments; however, decreased 
cell viability was observed during co-treatment of 1000 μM fatty acid and Mn so these data 
were not reported. 
2.2. 3H-GABA uptake 
Uptake of tritiated GABA (3H-GABA) was measured as described by Erikson and Aschner 
(2002). Astrocytes (90% confluent in 6-well plates) were incubated for 1, 6, or 24 h at 37 °C 
with treatment media containing 0 or 500 μM Mn in the form of MnCl2. An additional group of 
control astrocytes received 500 μM Mn (CnMn) in the experimental buffer only for the duration 
of the uptake experiment. The CnMn group simulates Mn in the extracellular space, and was 
used to observe the interaction of Mn with extracellular GABA and GABA transport proteins. 
Cells were washed 3× with HEPES buffer [122 mM NaCl, 3.3 mM KCl, 0.4 mM MgSO4, 
1.3 mM CaCl2, 1.2 mM KH2PO4, 10 mM glucose, and 25 mM N-2-hydroxy-ethylpiperanzine N'-
2-ethansulfonic acid, pH 7.4] and incubated for 1, 2, or 4 min with HEPES buffer containing 
0.5 μCi 3H-GABA (PerkinElmer) and cold GABA (Sigma–Aldrich) resulting in a final 
concentration of 50 μM total GABA. The reaction was stopped by aspirating the tritiated 
HEPES and washing the cells 4× with cold (4 °C) 290 mM mannitol buffer containing 
0.5 mM calcium nitrate to maintain cell adhesion to the substrate. Cells were solubilized in 
500 μL NaOH (1 N) and 400 μL aliquots were neutralized with 33.3 μL HCl (12 N) then used 
for β-counting with a Perkin Elmer liquid scintillation analyzer (PerkinElmer). The remaining 
100 μL was used for protein determination using the bicinchoninic assay (BCA, Pierce 
Chemicals). 
2.3. Cell fractionation 
Astrocyte cytosolic and membrane fractions were obtained through differential centrifugation. 
Astrocytes from two 100 mm plates were pooled into 1 mL phosphate buffered saline (PBS), 
centrifuged (1000 × g) to pellet, then rinsed with PBS and re-pelleted twice. The PBS was then 
aspirated and 100 μL cold 0.32 M sucrose pH 7.4 containing a protease inhibitor cocktail 
(Calbiochem) and phosphatase inhibitors sodium orthovanadate, sodium fluoride, and β-
glycerolphosphate (Sigma–Aldrich) was added to the final pellet to maintain membrane integrity. 
The pellet was sonicated on ice using ten one-second bursts. The remaining homogenate was 
centrifuged at 750 × g for 5 min to pellet nuclear material and any unbroken cells. The 
supernatant was decanted and centrifuged at 41,000 × g for 30 min at 4 °C. The resulting 
supernatant and pellet were separated and represent the cytosol and crude membrane fractions, 
respectively. The crude membrane fraction was solubilized in 100 μL radioimmunoprecipitation 
assay (RIPA) lysis buffer (99 mL 1× PBS, 1 mL Nonidet 40, 0.1 g sodium dodecyl sulfate, 
0.5 g sodium deoxycholate, pH 7.4). Cellular fractions of astrocytes were obtained from least 
three independent culture dates and used for western blot and metal analyses. 
2.4. Western blot analysis 
Protein concentrations of cytosolic and plasma membrane samples were determined using BCA 
analysis. For western blots, 20 μg of protein from each sample was loaded into NuPAGE® Bis-
Tris precast gels, run with MES running buffer for 40 min using NuPAGE® preset conditions on 
the PowerEase® 500 power supply system, and transferred to a Immobilon® PVDF membrane 
(Millipore) for 1 h using the XCell II™ blot module in transfer buffer (all from Invitrogen). The 
following antibodies and dilutions were used for protein detection: GAT3 1:500 (Abcam), 
phospho-PKC (pan, βII Ser 660) 1:1000 (Cell Signaling), PKC (pan, Thr 495) 1:1000 (Novus 
Biologicals), β-Actin 1:1000–1:5000 (Cell Signaling), and anti-rabbit IgG HRP-linked 
secondary (Cell Signaling). Immunoblotting occurred overnight at 4 °C after membranes were 
blocked with Tris-buffered saline containing tween (TBST, 2.42 g Tris, 8 g NaCl, 1 L deionized 
water, 500 μL Tween 20, pH 7.6) and 5% instant milk. The membrane was then rinsed 4× with 
TBST and blocked again with 5% milk prior to being exposed to the secondary antibody for 2 h 
at room temperature. Protein detection was acquired using Western Lighting Chemiluminescence 
(PerkinElmer) on a BioRad Chemidoc imaging system, and the band signal intensity was 
assessed using QuantityOne software (BioRad). 
2.5. Metal analysis 
Mn concentrations were measured with graphite furnace atomic absorption spectrometry (Varian 
AA240, Varian, Inc., USA). Aliquots of astrocyte cytosolic and plasma membrane homogenates 
(30 μL) were digested in ultra-pure nitric acid (1:2 v/v dilution) for 24–48 h in a sand bath 
(60 °C). Each sample was further diluted with a 2% nitric acid solution as needed for analysis. 
A bovine liver (NBS Standard Reference Material, USDC, Washington, DC) (10 μg Mn/g) was 
digested in ultrapure nitric acid and used as an internal standard for analysis (final concentration 
5 μg Mn/L). Metal data are expressed as μM/mg protein. 
2.6. Statistical analysis 
3H-GABA uptake and metal data were analyzed using SPSS v20 for Windows. Data were 
examined for the presence of outliers by boxplot analysis. Analysis of variance was conducted to 
identify mean differences between treatment groups for uptake and metal analyses with a 
significance threshold set at p < 0.05. Tukey's post hoc tests were conducted when a significant 
difference in means was detected to identify significant variations among individual treatments 
within the statistical model. Pearson's correlational analyses were then performed to examine 
relationships between metal concentrations and 3H-GABA uptake. The threshold of significance 
for all tests was set at p < 0.05. 
3. Results 
3.1. Mn decreases 3H-GABA uptake in a PKC independent manner 
A time dependent decrease in 3H-GABA uptake was observed in astrocytes exposed to 500 μM 
Mn (Fig. 1A). Mn significantly reduced GABA uptake after 24 h of exposure (p < 0.001) and in 
astrocytes that were only exposed to Mn (CN Mn) during experimental conditions (p < 0.05), 
compared to control. The CN Mn group was added to identify the effect of extracellular Mn on 
GABA uptake. A time dependent increase in PKC phosphorylation (pPKC) was also observed 
with Mn exposure ( Fig. 1B); however, no appreciable changes in plasma membrane or cytosolic 
GAT3 protein levels resulted due to elevated pPKC, contrary to our hypothesis. To further 
investigate the involvement of PKC in Mn reduced GABA transport we repeated the uptake 
experiments using the PKC inhibitors BIS II and isorhamnetin (ISO). Pretreatment with 10 μM 
ISO failed to restore Mn-impaired GABA uptake ( Fig. 1C), despite decreasing pPKC in the 
plasma membrane fraction ( Fig. 1D); furthermore, ISO reduced GABA uptake when Mn was 
present in the extracellular space (Fig. 1C). Slight reductions in membrane bound GAT3 were 
observed with ISO treatment corroborating decreased uptake. ISO driven changes in membrane 
GAT3 is not likely due to PKC signaling because 24 h Mn exposure did not yield similar results 
although pPKC was abundant. Moreover, treatment with the broad PKC inhibitor BIS II (10 μ
M) did not restore Mn-impaired GABA uptake (data not shown) further supporting a diminished 
role of PKC phosphorylation in Mn reduced GABA uptake. 
 
Fig. 1. 3H-GABA uptake and GAT3 protein levels in Mn exposed astrocytes. Mn and isorhamnetin (ISO) 
significantly reduce 3H-GABA uptake independent of PKC phosphorylation. (A) 3H-GABA uptake, 
reported as specific activity (SA), of astrocytes exposed for 2 min to an experimental buffer containing 
0.5 μCi 3H-GABA (total GABA concentration, 50 μM). Prior to uptake, astrocytes were exposed to 
500 μM Mn for 0 (control), 1, 6, or 24 h. An additional group of control astrocytes were exposed to 
experimental buffer containing 3H-GABA and 500 μM Mn (CN Mn) to simulate extracellular Mn. (C) 
2 min uptake of 3H-GABA in astrocytes pretreated for 72 h with 10 μM ISO, ISO plus extracellular Mn 
(ISO ExMn), and 24 h Mn exposure after ISO pretreatment (ISO Mn 24 h). All uptake data represent 
three sample replicates from three independent culture dates (n = 9) and are expressed as mean specific 
activity normalized to protein ± SEM. (B and D) Western blot analysis on cytosolic and plasma 
membrane fractions of cells exposed to 500 μM Mn for 0, 1, 6, or 24 h (B), or 24 h exposure to Mn after 
pretreatment with ISO (D). An additional group of cells were treated with 50 μM GABA (G50) (D) to 
control for protein expression changes due to the uptake experimental conditions. Analysis of variance 
was performed on uptake data, and when applicable, Tukey's post hoc analysis was conducted to 
determine significant differences between treatment groups, (*) p ≤ 0.05. 
3.2. Membrane GAT3 may be influenced by cellular Mn localization 
Metal analysis of membrane and cytosolic fractions provide novel data that suggest Mn and ISO 
induced changes in GABA uptake may be associated with cellular Mn localization. Astrocytes 
exposed to 500 μM Mn rapidly accumulate cytosolic Mn by 600-fold within 1 h of exposure, 
followed by drastic Mn efflux resulting in a net retention of cytosolic Mn that is ∼100-fold 
greater compared to control (Fig. 2A). Interestingly, ISO pretreatment blunted cytosolic Mn 
accumulation by 60% after 1 and 6 h of Mn exposure, but cytosolic Mn normalized after 24 h 
(Fig. 2A and B). Cytosolic and membrane Mn levels were significantly elevated from controls 
after 24 h of Mn exposure (p < 0.05), corresponding with significantly reduced GABA uptake 
but stable membrane GAT3 levels. Decreased Mn uptake in the ISO treatment group, and a near 
significant (p = 0.06) reduction in membrane Mn levels compared to the Mn alone treatment, 
may allow for proper GAT3 membrane recycling. 
  
Fig. 2. Astrocyte Mn accumulation after Mn exposure and ISO pretreatment. (A) Astrocytes exposed to 
500 μM Mn responded with rapid accumulation of cytosolic Mn after 1 h of exposure but retained less 
cytosolic Mn with longer term exposure. The Mn content in plasma membrane fractions of astrocytes 
responded similarly over time with less magnitude of change. After 24 h of Mn exposure, cytosolic and 
membrane Mn concentrations were significantly elevated compared to control (B). Pretreatment with ISO 
blunted the initial cytosolic accumulation of Mn (A), and caused a near significant (p = 0.06) reduction in 
plasma membrane Mn content after 24 h of Mn exposure (B). Data from control and 24 h time points 
were collected from three independent culture dates (n = 9), 1 h and 6 h Mn time points were pooled 
samples from three separate 100 mm plates. Analysis of variance was performed on metal analysis data, 
and when applicable, Tukey's post hoc analysis was conducted to determine significant differences 
between treatment groups, (*) p ≤ 0.05. 
3.3. Oleic acid and palmitic acid exacerbate Mn accumulation resulting in decreased GABA 
uptake 
Administration of oleic acid and palmitic acid to astrocyte cultures resulted in concentration 
dependent changes in GABA uptake (Fig. 3A). Low concentrations (10 μM) of oleic acid (O10) 
or palmitic acid (P10) had little effect on GABA uptake but a logarithmic increase in fatty acid 
dose (O100 or P100) reduced uptake. Mn exposure compounded this effect significantly 
impairing GABA uptake with 10 or 100 μM treatment of either fatty acid (Fig. 3A). Decreased 
uptake did not correspond with changes in GAT3 protein levels (Fig. 3B and C). The application 
of fatty acids did, however, enhance Mn accumulation in cytosolic and membrane fractions of 
astrocytes (Fig. 4A and B). Co-application of oleic acid and Mn significantly increased 
membrane Mn content (O10 Mn, p < 0.001; O100 Mn, p < 0.05) over Mn treatments alone ( Fig. 
4B). Similarly, combined palmitic acid and Mn applications significantly elevated membrane Mn 
levels over Mn treatments alone (P10 Mn and P100 Mn, p < 0.001), but palmitic acid also 
exacerbated Mn uptake leading to significantly greater cytosolic Mn concentrations than Mn 
treatment alone (p < 0.001) ( Fig. 4D). Correlational analysis revealed significant inverse 
relationships between GABA uptake and both cytosolic ( Fig. 4C, p < 0.05) and membrane ( Fig. 
4D, p < 0.05) Mn concentrations. Decreased uptake and augmented Mn accumulation with oleic 
acid and palmitic acid were not associated with changes in GAT3 protein levels ( Fig. 3B and C). 
 
Fig. 3. 3H-GABA uptake and western blot analysis of astrocytes exposed to oleic acid and palmitate. 
Astrocytes were exposed to oleic acid or palmitate (10 μM (O10 and P10) or 100 μM (O100 and P100)) 
for 24 h with or without 500 μM Mn. Uptake and western blot analyses were performed on astrocytes 
from three independent culture dates. Uptake samples (n = 9) and western blots are representative of 
protein changes from the three culture dates. (A) Oleic acid and palmitate significantly decrease 3H-
GABA uptake when combined with Mn exposure, but not independently. (B) Changes in 3H-GABA 
uptake did not correspond with changes in plasma membrane GAT3 content or PKC phosphorylation. 
Analysis of variance was performed on uptake data, and when applicable, Tukey's post hoc analysis was 
conducted to determine significant differences between treatment groups, p ≤ 0.05. 
 
 
Fig. 4. Cytosolic and plasma membrane metal content of astrocytes exposed to oleic acid and palmitate. 
Exposure to oleic acid and palmitate exacerbate Mn accumulation due to 500 μM Mn exposure in 
cytosolic and membrane fractions, and was negatively correlated with 3H-GABA uptake. Data represent 
three sample replicates from two independent culture dates (n = 6) and are expressed as μM Mn 
normalized to sample protein ± SEM. (A) Mn concentrations of cytosolic and membrane fractions of 
cells exposed to 10 or 100 μM fatty acid. (B) Co-treatment with 500 μM Mn and fatty acids enhance 
Mn accumulation in both cell fractions compared to control (*) and Mn exposure (†) alone. (C) 
Cytosolic Mn concentrations of Mn and fatty acid (FA) exposures had a significant negative correlation 
with 3H-GABA uptake. (D) A significant negative correlation was also observed between plasma 
membrane Mn content and 3H-GABA uptake of Mn and FA exposed astrocytes. Analysis of variance 
with Tukey's post hoc analysis was used to determine significant differences in Mn content between 
treatment groups, and Pearson's correlational analysis was conducted to elucidate the relationship 
between 3H-GABA uptake and Mn accumulation, p ≤ 0.05. 
3.4. Extracellular Mn and GABA interact reducing their transport into cells 
Astrocytes exposed to Mn only during the uptake experiment (CN Mn) had reduced GABA 
uptake similar to astrocytes that were exposed to Mn for 24 h (Fig. 1A). Additionally, 
extracellular Mn reduced GABA uptake in the ISO treatment group versus the ISO treatment 
without Mn in the experimental buffer (Fig. 1C). These data show that extracellular Mn 
decreases GABA uptake. Next we tested whether increasing concentrations of GABA had the 
same effect on Mn uptake. Astrocytes exposed to 10, 100, and 1000 μM Mn had significantly 
elevated cytosolic Mn compared to control (Fig. 5); however concomitant administration of 
50 μM GABA with 1000 μM Mn decreased cytosolic Mn concentrations compared with 
1000 μM Mn alone (p < 0.05) ( Fig. 5). 
 
Fig. 5. Dose response: cytosolic and membrane Mn concentrations with increasing Mn and GABA. These 
data represent cytosolic and membrane Mn concentrations of astrocytes exposed to logarithmic increases 
in Mn (10, 100, and 1000 μM) and GABA (50 and 500 μM) independent or in combination for 24 h. 
These data represent three pooled culture dishes from two culture dates. (n = 4). Analysis of variance with 
Tukey's post hoc analysis, were applicable, was used for statistical analysis. (*) represents a significant 
change from control and (†) represents a significant change from Mn 1000, p ≤ 0.05. 
4. Discussion 
The purpose of this study was to characterize how Mn decreases GABA uptake in primary 
astrocytes. Because astrocytes maintain the extracellular milieu around synaptic terminals, 
understanding how Mn and indirect consequences of Mn exposure (i.e. increased fatty acids) 
alter astrocyte GABA uptake is valuable to understand neurochemical changes associated with 
Mn neurotoxicity. These data corroborate previous findings of impaired GABA uptake extending 
to primary astrocytes and novel evidence that mechanisms driving this impairment involve Mn 
interacting with the plasma membrane. Additionally, our results show that increases in brain 
fatty acid levels associated with Mn neurotoxicity exacerbate the effect of Mn on GABA uptake 
by enhancing Mn accumulation in the membrane fraction of astrocytes. 
We hypothesized that Mn would decrease GABA uptake in astrocytes via PKC phosphorylation 
and internalization of GAT3. This assumption was based on data indicating that Mn activates 
PKC (Latchoumycandane et al., 2005 and Kitazawa et al., 2005), PKC mediates membrane 
recycling of GAT1 (Wang and Quick, 2005), and that Mn induced PKC activation led to 
internalization of other transporters in the Slc6 family (Sidoryk-Wegrzynowicz et al., 2011). We 
observed a time dependent increase in PKC phosphorylation with Mn exposure; however, this 
increase did not correspond with internalization of GAT3 protein (Fig. 1B). There is abundant 
evidence in the literature supporting the role of PKC in the regulation of GAT1 (Whitworth and 
Quick, 2001, Quick et al., 2004 and Wang and Quick, 2005), but a paucity of experimental 
studies examining GAT3 regulation. We measured both GAT1 (data not shown) and GAT3 in 
our primary astrocytes, but only detected the presence of GAT3. It is possible that GAT3 
regulation functions through different mechanisms, or that GAT3 does not recycle as 
dynamically as GAT1 to and from the plasma membrane. Alternatively, increased pPKC in 
astrocytes promotes SNARE protein interactions with GAT1 (and likely GAT3), which has been 
shown to stabilize GAT1 on the membrane, but due to conformational changes, decreases GAT 
function (Quick, 2006 and Wang et al., 2003). However, because the PKC inhibitors Bis II and 
ISO did not restore GABA uptake in our study, and the addition of Mn to the experimental buffer 
decreased uptake in control astrocytes, we postulate that Mn interacts directly with the plasma 
membrane and possibly the GAT proteins. Mn binding GATs could reduce GABA transport 
similar to decreased dopamine transporter (DAT) function upon zinc binding to extracellular 
loops of DATs (Norregaard et al., 1998). 
Mn is chaperoned by intra- and extra-cellular transport proteins, but once the need for Mn in 
metalloenzymes is met and storage mechanisms become overwhelmed, excess Mn can impair 
cellular respiration, induce lipid peroxidation, and initiate apoptosis (Malecki, 2001, Yiin et al., 
1996 and Yoon et al., 2011). The unbound species of Mn (Mn3+) is highly reactive and will 
quickly bind to sulfhydryl moieties of amino acid residues (Fisher and Jones, 1981) or scavenge 
electrons initiating oxidative damage. The production of F2-isoprostanes and increase of 
prostaglandin E2 due to Mn exposure demonstrates this reactivity (Milatovic et al., 2009), but 
also provides evidence that Mn interacts with the plasma membrane. Our data confirm that Mn 
content in the membrane fraction of astrocytes is significantly elevated with Mn exposure (Fig. 
5), and was also associated with decreased GABA uptake (Fig. 1A). Sulfhydryl containing 
cysteine residues on the short extracellular loop four of the GABA transporters are fundamental 
to sodium and GABA ligand binding for translocation to the cytosol (Zomot and Kanner, 2003). 
We hypothesize that interactions between Mn and these sulfhydryl residues are a putative 
mechanism for decreased GABA uptake in primary astrocytes. Additionally, the DAT (of the 
same, largely conserved, Slc6 transporter family as GAT isoforms) was identified to play a role 
in Mn transport in striatal synaptosomes and the globus pallidus of Mn exposed rats (Anderson et 
al., 2007b). It is possible that Mn has a similar affinity for GAT isoforms as DAT, accounting for 
a decline in GAT function. We observed that adding physiological concentrations of GABA 
(50 μM) to astrocyte cultures decreased cytosolic Mn accumulation (Fig. 5), and speculate that 
Mn interacts with extracellular GABA or competes as a ligand for GATs. To identify direct 
binding of Mn to GATs would require further studies using structural modeling to predict metal 
binding sites, similar to the elucidation of the zinc/DAT binding site, in conjunction with 
immunoprecipitation of GATs from Mn exposed cells followed by metal analysis of the eluted 
protein to identify Mn/GAT binding. 
Recently, data were published by our lab showing profound changes in brain lipid metabolism of 
Mn exposed rats (Fordahl et al., 2012). Significant elevations of oleic acid (12-fold), palmitic 
acid (15-fold), and cholesterol (4-fold) were observed. These fatty acids are primary constituents 
of plasma membrane and membrane raft composition (Schumann et al., 2011), and oleic and 
palmitic acid have been independently associated with decreased GABA uptake and increased 
PKC activity (Troeger et al., 1984, Khan et al., 1992 and Ragheb et al., 2009). Drastic changes in 
these fatty acids may contribute to GABA related dysfunction observed in Mn neurotoxicity; 
however to our knowledge this relationship has not been investigated. 
The effect of fatty acid treatment on GABA uptake observed in our study was less than 
previously reported (Troeger et al., 1984 and Rhoads et al., 1982). A significant decline in 
GABA uptake was only achieved when oleic acid or palmitate were co-administered with Mn. 
Again, PKC associated internalization of GAT3 did not occur with either fatty acid alone or 
combined fatty acid/Mn treatments (Fig. 3B and C). Changes in the amount of these fatty acids, 
specifically the saturated fatty acid palmitate, may compromise the membrane fluidity and 
impair protein-mediated transport (Hulbert et al., 2005). Oleic acid is one of the most abundant 
fatty acids in the plasma membrane, and oleic and palmitic acids are the predominant fatty acids 
found in membrane lipid rafts (Schumann et al., 2011). Disrupting lipid composition in 
membrane rafts resulted in a 50% decrease in transport rate by GATs (North and Fleischer, 
1982 and Allen et al., 2007). Since GATs are associated with lipid raft micro-domains (Allen et 
al., 2007) the debilitating effect of fatty acids and Mn on GABA uptake observed in our study 
could be influenced by changes in lipid raft composition. Moreover, oleic and palmitic acids 
significantly elevated Mn accumulation in membrane fractions over Mn exposure alone. It is 
unclear whether decreased GABA uptake is primarily affected by Mn directly or Mn induced 
changes in fatty acids, but our data show a synergistic relationship between the two. 
While direct binding of Mn to GATs needs to be confirmed, we provide evidence that an 
interaction between Mn and these transmembrane proteins may exist. Furthermore, it appears 
that Mn exposure does not profoundly alter cellular localization of GAT3 in primary astrocytes, 
specifically via PKC signaling. It is possible that endoplasmic reticular stress compromises post 
translational modification of neurotransmitter transporters, but results from this and previous 
studies from our lab suggest that Mn exposure alters membrane structure/function as evidenced 
by the oleic acid, palmitic acid, and cholesterol changes in vivo with Mn exposure (Fordahl et 
al., 2012) and their influence on in vitro GABA uptake. These changes may influence membrane 
dynamics, and our data suggest that elevations of these fatty acids augment Mn aggregation at 
the membrane where Mn is available to interact with transmembrane proteins or instigate 
oxidative damage. Further characterizing the effects of Mn accumulation on membrane integrity 
will provide valuable information on how Mn neurotoxicity affects GABA and other 
neurotransmitter systems within the basal ganglia. 
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